Home>Topics>Stocks>Keryx Biopharmaceuticals

Keryx Biopharmaceuticals KERX

  1. All
  2. Commentary
  3. Headlines
    1. Keryx Biopharmaceuticals : Is The High Valuation Justified?

      Headlines

      Wed, 16 Apr 2014

      opportunities. However, at the same time it has also brought in focus, high valuations of stocks like Keryx Biopharmaceuticals ( KERX ) that appreciated more than 100% in last one year and more than 400% since 2012. Investor interest in

    2. High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued

      Headlines

      Tue, 1 Apr 2014

      we wrote about in a positive light last year because of an excellent chance of long-term success is Keryx Pharmaceuticals ( KERX ) . We accurately predicted the price run-up and wrote, We believe Keryx can run up to about $10 a share before the near

    3. Keryx longs break out the champagne

      Headlines

      Wed, 26 Mar 2014

      Shareholders of Keryx Biopharmaceuticals ( KERX ) want to give Congress a hug after its proposal to delay putting ESRD drugs into to the ACA-mandated payment bundle until 2024

    4. Midday Gainers /Losers

      Headlines

      Wed, 26 Mar 2014

      Top 10 Gainers: ISR +26% . OTCQB:XXII +20% . ETAK +18% . KERX +18% . FFHL +17% . CXDC +14% . YONG +13% . EMAN +13% . SCS +12% . THTI +12% . Top 10 Losers: EXEL -36% . BODY

    5. Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

      Headlines

      Thu, 13 Mar 2014

      Keryx Biopharmaceuticals ( KERX ) Q4 2013 Earnings Conference ..... Greetings and welcome to the Keryx Biopharmaceuticals Investor Conference Call ..... Chief Financial Officer for Keryx Biopharmaceuticals . Thank you sir, you may

    6. Keryx Biopharmaceuticals misses by $0.05.

      Headlines

      Wed, 12 Mar 2014

      Keryx Biopharmaceuticals ( KERX ): Q4 EPS of -$0.21 misses by $0.05 . Press Release Post your comment!

    7. Keryx says kidney drug effective; shares hit seven-year high

      Headlines

      Tue, 5 Nov 2013

      (Reuters) - Keryx Biopharmaceuticals Inc's kidney drug proved effective in treating chronic kidney disease patients not on dialysis, sending the company's shares to a seven-year high on hopes the...

    8. 5 Investing Tricks Of The Trade For Your Arsenal

      Headlines

      Mon, 18 Mar 2013

      By Quoth the Raven : Introduction In an effort to find niche investing moves that I feel most traders don't take advantage of, I spent a day brainstorming with a friend of mine over some of the lesser used "tricks" we sometimes use to invest. These are small items that we've learned over time that

    9. Uncertainty looms over Keryx, Aeterna cancer drug

      Headlines

      Mon, 2 Apr 2012

      (Reuters) - Keryx Biopharmaceuticals Inc and Aeterna Zentaris said their experimental colorectal cancer drug did not meet the main goal of a late-stage trial, raising doubts on the drug's future as a...

    10. Dropping Coverage of Keryx

      Commentary

      Mon, 3 Aug 2009

      We are no longer providing equity research on Keryx Biopharmaceuticals KERX . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.

    « Prev12Next »
    Content Partners